The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Fungal Infections in Recipients of Hematopoietic Stem Cell Transplants: Results of the SEIFEM B-2004 Study--Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne
Open accessAbstract
BACKGROUND: The purpose of our study was to evaluate the incidence and outcome of invasive fungal infection (IFI) among patients who underwent autologous or allogeneic hematopoietic stem cell transplantation (HSCT) at 11 Italian transplantation centers. METHODS: This cohort-retrospective study, conducted during 1999-2003, involved HSCT patients admitted to 11 tertiary care centers or university hospitals in Italy, who developed IFIs (proven or probable). RESULTS: Among 3228 patients who underwent HSCT (1249 allogeneic HSCT recipients and 1979 autologous HSCT recipients), IFI occurred in 121 patients (overall incidence, 3.7%). Ninety-one episodes (2.8% of all patients) were due to molds, and 30 (0.9%) were due to yeasts. Ninety-eight episodes (7.8%) occurred among the 1249 allogeneic HSCT recipients, and 23 (1.2%) occurred among the 1979 autologous HSCT recipients. The most frequent etiological agents were Aspergillus species (86 episodes) and Candida species (30 episodes). The overall mortality rate was 5.7% among allogeneic HSCT recipients and 0.4% among autologous HSCT recipients, whereas the attributable mortality rate registered in our population was 65.3% (72.4% for allogeneic HSCT recipients and 34.7% for autologous HSCT recipients). Etiology influenced the patients' outcomes: the attributable mortality rate for aspergillosis was 72.1% (77.2% and 14.3% for allogeneic and autologous HSCT recipients, respectively), and the rate for Candida IFI was 50% (57.1% and 43.8% for allogeneic and autologous HSCT recipients, respectively). CONCLUSIONS: IFI represents a common complication for allogeneic HSCT recipients. Aspergillus species is the most frequently detected agent in these patients, and aspergillosis is characterized by a high mortality rate. Conversely, autologous HSCT recipients rarely develop aspergillosis, and the attributable mortality rate is markedly lower. Candidemia was observed less often than aspergillosis among both allogeneic and autologous HSCT recipients; furthermore, there was no difference in either the incidence of or the attributable mortality rate for candidemia among recipients of the 2 transplant types.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1990) · Choice Reviews Online · doi:10.5860/choice.27-3338 · Cited by 35,305
Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
Herbrecht, R., Denning, D. W., Patterson, T. F., Bennett, J. E., Greene, R. E., Oestmann, J.-W., Kern, W. V., Marr, K. A., Ribaud, P., Lortholary, O., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020191 · Cited by 3,304
Infectious Diseases Society of America
Enders, J. F. (1969) · Journal of Infectious Diseases · doi:10.1093/infdis/119.3.317 · Cited by 3,286
Ascioglu, S., Rex, J. H., de Pauw, B., Bennett, J. E., Bille, J., Crokaert, F., Denning, D. W., Donnelly, J. P., Edwards, J. E., Erjavec, Z., et al. (2002) · Clinical Infectious Diseases · doi:10.1086/323335 · Cited by 2,331
Denning, D. W. (1998) · Clinical Infectious Diseases · doi:10.1086/513943 · Cited by 1,492
Epidemiology and Outcome of Mould Infections in Hematopoietic Stem Cell Transplant Recipients
Marr, K. A., Carter, R. A., Crippa, F., Wald, A., & Corey, L. (2002) · Clinical Infectious Diseases · doi:10.1086/339202 · Cited by 1,448
Aspergillosis Case-Fatality Rate: Systematic Review of the Literature
Lin, S.-J., Schranz, J., & Teutsch, S. M. (2001) · Clinical Infectious Diseases · doi:10.1086/318483 · Cited by 1,409
Marr, K. A., Carter, R. A., Boeckh, M., Martin, P., & Corey, L. (2002) · Blood · doi:10.1182/blood-2002-05-1496 · Cited by 957
Practice Guidelines for the Treatment of Candidiasis
Rex, J. H., Walsh, T. J., Sobel, J. D., Filler, S. G., Pappas, P. G., Dismukes, W. E., & Edwards, J. E. (2000) · Clinical Infectious Diseases · doi:10.1086/313749 · Cited by 927
(2006) · PubMed · Cited by 906
Invasive Aspergillosis Disease Spectrum, Treatment Practices, and Outcomes
Patterson, T. F., Kirkpatrick, W. R., White, M., Hiemenz, J. W., WINGARD, J. R., DUPONT, B., RINALDI, M. G., STEVENS, D. A., & Graybill, J. R. (2000) · Medicine · doi:10.1097/00005792-200007000-00006 · Cited by 791
Practice Guidelines for Diseases Caused by Aspergillus
Stevens, D. A., Kan, V. L., Judson, M. A., Morrison, V. A., Dummer, S., Denning, D. W., Bennett, J. E., Walsh, T. J., Patterson, T. F., & Pankey, G. A. (2000) · Clinical Infectious Diseases · doi:10.1086/313756 · Cited by 789
Walsh, T. J., Raad, I., Patterson, T. F., Chandrasekar, P., Donowitz, G. R., Graybill, R., Greene, R. E., Hachem, R., Hadley, S., Herbrecht, R., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/508774 · Cited by 752
Wald, A., Leisenring, W., van Burik, J., & Bowden, R. A. (1997) · The Journal of Infectious Diseases · doi:10.1086/516480 · Cited by 742
Kontoyiannis, D. P., Lionakis, M. S., Lewis, R. E., Chamilos, G., Healy, M., Perego, C., Safdar, A., Kantarjian, H., Champlin, R., Walsh, T. J., et al. (2005) · The Journal of Infectious Diseases · doi:10.1086/428780 · Cited by 674
Maertens, J., Raad, I., Petrikkos, G., Boogaerts, M., Selleslag, D., Petersen, F. B., Sable, C. A., Kartsonis, N. A., Ngai, A., Taylor, A., et al. (2004) · Clinical Infectious Diseases · doi:10.1086/423381 · Cited by 658
Maertens, J., Theunissen, K., Verhoef, G., Verschakelen, J., Lagrou, K., Verbeken, E., Wilmer, A., Verhaegen, J., Boogaerts, M., & Eldere, J. V. (2005) · Clinical Infectious Diseases · doi:10.1086/496927 · Cited by 592
Upton, A., Kirby, K. A., Carpenter, P., Boeckh, M., & Marr, K. A. (2007) · Clinical Infectious Diseases · doi:10.1086/510592 · Cited by 514
Mukherjee, P. K., Chandra, J., Kuhn, D. M., & Ghannoum, M. A. (2003) · Infection and Immunity · doi:10.1128/iai.71.8.4333-4340.2003 · Cited by 511
Marr, K. A., Seidel, K., White, T. C., & Bowden, R. A. (2000) · The Journal of Infectious Diseases · doi:10.1086/315193 · Cited by 493
Fukuda, T., Boeckh, M., Carter, R. A., Sandmaier, B. M., Maris, M. B., Maloney, D. G., Martin, P. J., Storb, R. F., & Marr, K. A. (2003) · Blood · doi:10.1182/blood-2003-02-0456 · Cited by 465
Morgan, J., Wannemuehler, K. A., Marr, K. A., Hadley, S., Kontoyiannis, D. P., Walsh, T. J., Fridkin, S. K., Pappas, P. G., & Warnock, D. W. (2005) · Medical Mycology · doi:10.1080/13693780400020113 · Cited by 407
Invasive Mold Infections in Allogeneic Bone Marrow Transplant Recipients
Baddley, J. W., Stroud, T. P., Salzman, D., & Pappas, P. G. (2001) · Clinical Infectious Diseases · doi:10.1086/319985 · Cited by 364
Mucormycosis in hematologic patients.
Pagano, L., Offidani, M., Fianchi, L., Nosari, A., Candoni, A., Picardi, M., Corvatta, L., D’Antonio, D., Girmenia, C., Martino, P., et al. (2004) · PubMed · Cited by 302
Self-citationIncidence and risk factors for invasive fungal infections in allogeneic BMT recipients
Jantunen, E., Ruutu, P., Niskanen, L., Volin, L., Parkkali, T., Koukila-Kähkölä, P., & Ruutu, T. (1997) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1700737 · Cited by 251
Zaoutis, T. E., Heydon, K., Chu, J. H., Walsh, T. J., & Steinbach, W. J. (2006) · Pediatrics · doi:10.1542/peds.2005-1161 · Cited by 241
Martino, R., Subirá, M., Rovira, M., Solano, C., Vázquez, L., Sanz, G. F., Urbano‐Ispizua, A., Brunet, S., De la Cámara, R., & (GETH), F. T. A. I. C. S. O. T. G. E. D. T. H. (2002) · British Journal of Haematology · doi:10.1046/j.1365-2141.2002.03259.x · Cited by 221
Grow, W., Moreb, J., Roque, D., Manion, K., Leather, H., Reddy, V, Khan, S., Finiewicz, K., Nguyen, H., Clancy, C., et al. (2002) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1703332 · Cited by 192
Cornet, M., Fleury, L., Maslo, C., Bernard, J.-F., & Brücker, G. (2002) · Journal of Hospital Infection · doi:10.1053/jhin.2002.1258 · Cited by 169
Kami, M., Machida, U., Okuzumi, K., Matsumura, T., Mori, S., Hori, A., Kashima, T., Kanda, Y., Takaue, Y., Sakamaki, H., et al. (2002) · British Journal of Haematology · doi:10.1046/j.1365-2141.2002.03414.x · Cited by 111
Risk factors for invasive aspergillosis in neutropenic patients with hematologic malignancies
Mühlemann, K., Wenger, C., Zenhäusern, R., & Täuber, M. G. (2005) · Leukemia · doi:10.1038/sj.leu.2403674 · Cited by 96
Infectious complications after autologous CD34-selected peripheral blood stem cell transplantation
Crippa, F., Holmberg, L., Carter, R. A., Hooper, H., Marr, K. A., Bensinger, W., Chauncey, T. R., Corey, L., & Boeckh, M. (2002) · Transplantation and Cellular Therapy · doi:10.1053/bbmt.2002.v8.pm12064366 · Cited by 95
High Rate of Invasive Fungal Infections Following Nonmyeloablative Allogeneic Transplantation
Hagen, E. A., Stern, H., Porter, D., Duffy, K. M., Foley, K., Luger, S. M., Schuster, S. J., Stadtmauer, E. A., & Schuster, M. G. (2003) · Clinical Infectious Diseases · doi:10.1086/344906 · Cited by 94
Risk of resistance associated with fluconazole prophylaxis: Systematic review
Brion, L. P., Uko, S. E., & Goldman, D. L. (2007) · Journal of Infection · doi:10.1016/j.jinf.2006.11.017 · Cited by 90
The epidemiology of fusariosis in patients with haematological diseases
Girmenia, C., Pagano, L., Corvatta, L., Mele, L., Favero, A. D., & Pr, P. M. F. T. G. I. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.02312.x · Cited by 78
Self-citationLionakis, M. S., Lewis, R. E., Torres, H. A., Albert, N. D., RAAD, I. I., & Kontoyiannis, D. P. (2005) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2005.01.001 · Cited by 78
Jantunen, E., Salonen, J. H., Juvonen, E., Koivunen, E., Siitonen, T., Lehtinen, T., Kuittinen, O. M., Leppä, S., Anttila, V.-J., Itälä, M., et al. (2004) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2004.00273.x · Cited by 77
Kume, H., Yamazaki, T., Abe, M., TANUMA, H., Okudaira, M., & Okayasu, I. (2003) · Pathology International · doi:10.1046/j.1440-1827.2003.01548.x · Cited by 74
Nucci, M., Spector, N., Bueno, A. P. S., Solza, C., Perecmanis, T., Bacha, P. C., & Pulcheri, W. (1997) · Clinical Infectious Diseases · doi:10.1093/clind/24.4.575 · Cited by 72
Emergence of opportunistic mould infections in the hematopoietic stem cell transplant patient
Upton, A., & Marr, K. A. (2006) · Current Infectious Disease Reports · doi:10.1007/s11908-006-0017-5 · Cited by 49
Kojima, R., Kami, M., Nannya, Y., Kusumi, E., Sakai, M., Tanaka, Y., Kanda, Y., Mori, S.-I., Chiba, S., Miyakoshi, S., et al. (2004) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2004.06.003 · Cited by 39
Gualco, L., Debbia, E. A., Bandettini, R., Pescetto, L., Cavallero, A., Ossi, M. C., Schito, A. M., & Marchese, A. E. (2006) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2006.08.047 · Cited by 33
Cited by
Kontoyiannis, D. P., Marr, K. A., Park, B. J., Alexander, B. D., Anaissie, E. J., Walsh, T. J., Ito, J., Andes, D. R., Baddley, J. W., Brown, J. M., et al. (2010) · Clinical Infectious Diseases · doi:10.1086/651263 · Cited by 1,456
Global Epidemiology of Mucormycosis
Prakash, H., & Chakrabarti, A. (2019) · Journal of Fungi · doi:10.3390/jof5010026 · Cited by 938
Neofytos, D., Horn, D., Anaissie, E., Steinbach, W., Olyaei, A., Fishman, J., Pfaller, M., Chang, C., Webster, K., & Marr, K. (2009) · Clinical Infectious Diseases · doi:10.1086/595846 · Cited by 801
Changes in the epidemiological landscape of invasive candidiasis
Lamoth, F., Lockhart, S. R., Berkow, E. L., & Calandra, T. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx444 · Cited by 547
Epidemiological trends in invasive aspergillosis in France: the SAIF network (2005–2007)
Lortholary, O., Gangneux, J.-P., Sitbon, K., Lebeau, B., de Monbrison, F., Le Strat, Y., Coignard, B., Dromer, F., & Bretagne, S. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03548.x · Cited by 331
Metadata
- Authors
- Pagano, L., Caira, M., Nosari, A., Van Lint, M. T., Candoni, A., Offidani, M., Aloisi, T., Irrera, G., Bonini, A., Picardi, M., Caramatti, C., Invernizzi, R., Mattei, D., Melillo, L., de Waure, C., Reddiconto, G., Fianchi, L., Valentini, C. G., Girmenia, C., Leone, G., & Aversa, F.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-11-01
- Volume
- 45
- Issue
- 9
- Pages
- 1161-1170
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2109148349
- Cited by
- 414
- References
- 42
- FWCI
- 16.45
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.